ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 56 filers reported holding ODONATE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $7,252,000 | +10.3% | 377,700 | -22.8% | 0.15% | -7.8% |
Q3 2020 | $6,573,000 | -64.5% | 489,432 | +11.9% | 0.17% | -67.1% |
Q2 2020 | $18,512,000 | +55.9% | 437,231 | +1.7% | 0.51% | +3.5% |
Q1 2020 | $11,872,000 | -14.9% | 430,000 | 0.0% | 0.49% | +11.3% |
Q4 2019 | $13,954,000 | +24.7% | 430,000 | 0.0% | 0.44% | -1.1% |
Q3 2019 | $11,193,000 | -29.1% | 430,000 | 0.0% | 0.45% | -21.9% |
Q2 2019 | $15,777,000 | +60.4% | 430,000 | -3.4% | 0.57% | +50.7% |
Q1 2019 | $9,839,000 | +57.0% | 445,000 | 0.0% | 0.38% | +28.0% |
Q4 2018 | $6,266,000 | -25.9% | 445,000 | +2.2% | 0.30% | -3.3% |
Q3 2018 | $8,453,000 | -3.7% | 435,500 | +9.5% | 0.31% | -9.5% |
Q2 2018 | $8,782,000 | +8.1% | 397,750 | +3.7% | 0.34% | -2.6% |
Q1 2018 | $8,123,000 | -20.8% | 383,500 | -6.5% | 0.35% | -25.4% |
Q4 2017 | $10,250,000 | – | 410,000 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 14,075,269 | $595,947,000 | 57.94% |
Samsara BioCapital, LLC | 496,505 | $21,022,000 | 6.76% |
Boxer Capital, LLC | 3,363,377 | $142,405,000 | 6.26% |
Opaleye Management Inc. | 250,000 | $10,585,000 | 2.14% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 785,913 | $33,276,000 | 0.81% |
RTW INVESTMENTS, LP | 481,027 | $20,367,000 | 0.57% |
Birchview Capital, LP | 20,000 | $847,000 | 0.51% |
Rock Springs Capital Management LP | 437,231 | $18,512,000 | 0.51% |
Redmile Group, LLC | 633,038 | $26,803,000 | 0.50% |
SABBY MANAGEMENT, LLC | 40,500 | $1,715,000 | 0.34% |